Ensuring that clinical tests are not affected by tumor heterogeneity requires a sampling methodology that captures the genomic, proteomic, and cellular diversity of entire solid tumors. However, today ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback